Funds to be used for general corporate purposes, sales and marketing
By Devika Patel
Knoxville, Tenn., Nov. 1 - Miraculins Inc. said it raised C$602,000 in the second and final tranche of a C$1.03 million non-brokered private placement of units. The deal priced for C$1 million Sept. 12 and raised C$430,000 on Sept. 20.
The company sold 17.2 million units of one common share and a half-share warrant at C$0.06 per unit. It sold 7,166,667 units in the initial tranche and 10,033,333 units in the second tranche.
Each whole warrant is exercisable at C$0.10 for one year. The strike price is a 66.67% premium to the Sept. 11 closing share price of C$0.06.
Proceeds will be used for general corporate purposes including sales and marketing costs.
Based in Winnipeg, Man., Miraculins is a medical diagnostic development company focused on non-invasive tests for unmet clinical needs.
| Issuer: | Miraculins Inc.
|
| Issue: | Units of one common share and a half-share warrant
|
| Amount: | C$1,032,000
|
| Units: | 17.2 million
|
| Price: | C$0.06
|
| Warrants: | One half-share warrant per unit
|
| Warrant expiration: | One year
|
| Warrant strike price: | C$0.10
|
| Agent: | Non-brokered
|
| Pricing date: | Sept. 12
|
| Settlement dates: | Sept. 20 (for C$430,000), Nov. 1 (for C$602,000)
|
| Stock symbol: | TSX Venture: MOM
|
| Stock price: | C$0.06 at close Sept. 11
|
| Market capitalization: | C$6.72 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
